Select Medical Q3 2024 Earnings Report
Key Takeaways
Select Medical Holdings Corporation reported a 5.7% increase in revenue, reaching $1,761.2 million for the third quarter ended September 30, 2024. Net income increased by 33.2% to $81.0 million, and earnings per common share increased by 13.2% to $0.43.
Revenue increased by 5.7% to $1,761.2 million compared to the same quarter last year.
Net income increased by 33.2% to $81.0 million compared to the same quarter last year.
Earnings per common share increased by 13.2% to $0.43 compared to the same quarter last year.
The Board of Directors declared a cash dividend of $0.125 per share.
Select Medical
Select Medical
Select Medical Revenue by Segment
Forward Guidance
Select Medical is updating its 2024 business outlook, expecting revenue to be in the range of $6.95 billion to $7.15 billion, Adjusted EBITDA to be in the range of $865.0 million to $885.0 million, fully diluted earnings per share to be in the range of $2.01 to $2.12 and adjusted earnings per share to be in the range of $2.09 to $2.20.
Revenue & Expenses
Visualization of income flow from segment revenue to net income